Board approves amalgamation scheme with Zenith Healthcare Limited

Scheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.9%Reaction day

₹7.79

prior close

₹7.75

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-4.5% vs market

Pharmaceuticals peers, median of 165sector+0.0%-3.9% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 3.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.4

10m

-3.4

15m

-3.4

30m

+2.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.9+0.6-4.5+0.0-3.9

Next day

-8.6+0.2-8.8+0.0-8.6

-13.1-0.9-12.2-1.1-12.0

-8.9-0.3-8.6-0.4-8.4

-5.3+0.0-5.3-0.3-4.9

-7.6-1.1-6.4-1.6-6.0

-8.3-1.4-6.9-2.6-5.8

15d

-9.2+2.7-11.9-1.1-8.1

-9.4+3.6-12.9-0.4-8.9

-12.7+2.0-14.7-0.3-12.4

-29.8+1.1-30.9-2.2-27.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Achyut Healthcare board has approved a scheme to merge into Zenith Healthcare. Both firms share the same promoter group. Shareholders of Achyut will receive 119 equity shares of Zenith (face value INR 1) for every 50 shares held. Achyut will be dissolved without winding up. The scheme needs NCLT, shareholder and creditor approvals. Achyut has total assets of about INR 38 crore and turnover of about INR 12 crore as of March 2026.

Likely market impact

Shareholders will get Zenith shares per the swap ratio; deal needs NCLT and shareholder approvals before taking effect.